Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Plus Bendamustine in Frail Elderly DLBCL
NCT01990144Phase 2Unknown
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Nov 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in diffuse large B-cell lymphoma (DLBCL), sponsored by Fondazione Italiana Linfomi. Status: unknown.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01990144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990144.